Company type | Subsidiary of Pfizer |
---|---|
Industry |
Oncology Medication |
Founded | 1998 |
Founder | Drs. Tony Piscopio, Kevin Koch, David Snitman, and K.C. Nicolaou |
Headquarters | , |
Revenue | $173.8 million (2018) |
Parent | Pfizer |
Website |
www |
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is currently a subsidiary of Pfizer after being acquired for $11 billion in 2019.
In 1998, the company was founded by Drs. Tony Piscopio, Kevin Koch, David Snitman, and K.C. Nicolaou. [1]
In November 2000, the company became a public company via an initial public offering. [2]
In June 2019, Pfizer acquired the company for approximately $11 billion. [3]